All posts from in,

Meet Jeff Ubben

I'd like to introduce you to Jeff Ubben, the Valeant Pharmaceuticals Intl Inc (NYSE:VRX) (TSE:VRX) Pharmaceuticals of hedge fund managers. Wait...nevermind, you get the point. This is a short post, but packed with must-know, must-read info. First is a look at Jeff Ubben's ValueAct 13D performance. This is part of the activist performance database we're pumping. You can read more about it a recent blog post on our happenings.


Ubben has killed it. His average 13D is...